Generic Pharmaceutical Association logo

Member Log In

Same medicine. Same results. ™

  • GPhA Home
  • About GPhA
    • About Generics
      • Case for Generics
        • For Seniors
        • For Families
        • For Individuals
        • Same Medicine
        • Same Results
        • Paying for My Medications
          • Especially for Seniors
        • Generic Access
        • Looking for a Generic?
        • Recent Generic Approvals
        • Managing Your Medicines
          • For Parents
          • For Adults
          • For Seniors
        • Generics - Providing Savings for Americans
      • FAQ
      • Facts at a Glance
      • Helpful Links & Resources
        • Brochures
      • Glossary
    • Board of Directors
    • Staff
    • Industry History
    • Join GPhA
      • GPhA Member Benefits
    • Contact Us
  • Issues
    • Authorized Generics
    • Bioequivalence
    • Biogenerics
    • Carve-Outs
    • Citizen Petitions
    • Foreign Inspections / Reimportation
    • Free Trade Agreements
    • Medicaid
    • OGD Funding
    • Office of Generic Drugs
    • Patent Reform
    • Patent Settlements
    • Pedigree
    • Quality
    • Science Interaction
    • State Consumer Education Efforts
    • User Fees
  • Media
    • Press Releases
    • Media Kit
    • Testimony
    • Helpful Links & Resources
  • Events
    • Upcoming Events
    • Past Events
  • Get Involved
    • Discussing my Prescriptions with My Doctor and Pharmacist
    • Spreading the Word about Generics
    • Contact Congress
    • Media Guide Finder
    • Tell A Friend
Home

  • Authorized Generics
  • Bioequivalence
  • Biogenerics
  • Carve-Outs
  • Citizen Petitions
  • Foreign Inspections / Reimportation
  • Free Trade Agreements
  • Medicaid
  • OGD Funding
  • Office of Generic Drugs
  • Patent Reform
  • Patent Settlements
  • Pedigree
  • Quality
  • Science Interaction
  • State Consumer Education Efforts
  • User Fees

Authorized generics

GPhA Statement in Response to the Federal Trade Commission Interim Report on Authorized Generic Drugs

Press Release | June 24, 2009

GPhA Praises Emerson’s House Companion Version of Rockefeller Authorized Generic Bill

Press Release | August 1, 2006

Independent Analysis Reveals that Authorized Generics are Bad for Consumers, Lead to Higher Pharmaceutical Prices

Press Release | July 31, 2006

GPhA Says Rockefeller/Schumer/Leahy Bill Will Close Authorized Generic Loophole

Press Release | July 20, 2006

GPhA Statement on PhRMA Assessment of Authorized Generics

Press Release | June 28, 2006

GPhA Welcomes FTC's Consideration of Authorized Generics Study: 'Authorized Generics' Undermine Incentive to Produce Affordable Medicines

Press Release | May 12, 2005

GPhA: Reconciliation Bill Will Bring Savings to Taxpayers Through Change in Authorized Generics Calculation

Press Release | February 8, 2006

GPhA Welcomes FTC's Decision to Study Authorized Generics: 'Authorized Generics' Undermine Incentive to Produce Affordable Medicines

Press Release | November 9, 2005

FTC Commissioner Leibowitz speech before the American Bar Association

Federal Register Notice for the FTC Study

  • 1
  • 2
  • next ›
  • last »
Syndicate content
Generic Pharmaceutical Association logo
  • © 2010
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • Join